Drugging the cancer genome: large-scale objective assessment of potential targets and discovery of chaperone/stress pathway inhibitors

Professor Paul Workman, PhD, DSc, (Hon) FMedSci, FSB, FRSC, Deputy Chief Executive, The Institute of Cancer Research, Head, Division of Cancer Therapeutics, Director, Cancer Research UK Cancer Therapeutics Unit, Harrap Professor of Pharmacology and Therapeutics

When Jan 23, 2013 from 04:00 PM to 05:00 PM (US/Eastern / UTC-500)
Where 00-002 Joseph S. Pagano Conference Room, UNC Lineberger Cancer Center
Add event to calendar iCal

UNC Lineberger Cancer Center Weekly Seminar Series